 | Renal Association. Standards Subcommittee - Acute renal failure - 2002 - 216 pages
...of the European Society of Cardiology. Eur Heart J 1997; 18: 736-53. 56 Flather MD, Yusuf S, Kober L et al. Long-term ACE-inhibitor therapy in patients...Infarction Collaborative Group. Lancet 2000;355:1575-81. 58 Krumholz HM. b-blockers for mild to moderate heart failure. Lancet 1999;353:2-3. 59 Pitt B, Zannad... | |
 | Bernard Chanu, Bernard Jacotot - Coronary heart disease - 2002 - 230 pages
...AIRE Extension (AIREX) Study. Lancet 1997; 350(9074) : 366-7. -£ [20] Flather MD, Yusuf S., Kober L. et al. Long-term ACE-inhibitor therapy in patients...overview of data from individual patients. ACE-inhibitor 3 Myocardial Infarction Collaborative Group. Lancet 2000; 355(9215) : 1 575-81 . g [21] Swedberg K.,... | |
 | Deepak L. Bhatt, M. Flather - Acute diseases - 2004 - 507 pages
...left ventricular ejection fractions. N Engl J Med 1992;327:685-91. 27. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients...Infarction Collaborative Group. Lancet 2000:355:1575-81. 150 28. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor,... | |
 | R. Sean Morrison, Diane E. Meier - Medical - 2003 - 464 pages
...response to chronic heart failure. J Am Coll Cardiol 27:650-657, 1996. 9. Flather MD, Yusuf S, Kober L, et al. Longterm ACE-inhibitor therapy in patients...Myocardial Infarction Collaborative Group. Lancet 355:1575-1581, 2000. 10. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers... | |
 | Cardiovascular system - 2003 - 237 pages
...results. JAMA 1982; 247(12):1707-1714. (111) Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G et al. Long-term ACE-inhibitor therapy in patients...Myocardial Infarction Collaborative Group. Lancet 2000; 355(9215):1575-1581. (112) Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects... | |
 | Vicente Ortún Rubio - 2003 - 276 pages
...Circulation 1994; 90 (2): 762-768. 192.Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, y cols. Long-term ACE-inhibitor therapy in patients with heart...Myocardial Infarction Collaborative Group. Lancet 2000; 355 (9215): 1575-1581. 193.Heart Outcomes Prevention Evaluation Study Investigators Effects of... | |
 | Kyle Moylan, Tammy L. Lin - Medical - 2004 - 236 pages
...morbidity in patients with heart failure. JAMA 1995;273:1450-1456. 11. Flather MD, Yusuf S, Kaber L, et al. Long-term ACE-inhibitor therapy in patients...systematic overview of data from individual patients. Lancet 2000;355: 1575-1581. 12. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity... | |
 | Evidence-based medicine - 2004 - 474 pages
...left ventricular ejection fraction. N Engl J Med 1992; 327: 685-691. 62 Fiather MD, Yusuf S, Kober L et al.: Longterm ACE-inhibitor therapy in patients...Myocardial Infarction Collaborative Group. Lancet 2000; 355: 1575-1581. 63 Hall AS, Murray GD, Ball SG on behalf of the AIREX Study Investigators: Follow-up... | |
 | Thomas Unger, Bernward A. Schölkens - Biochemistry - 2004 - 634 pages
...with peripheral arterial disease. Atherosclerosis 145:51-60 Flather MC, Yusuf S, Kober L et al (2000) Long-term ACE-inhibitor therapy in patients with heart...systematic overview of data from individual patients. Lancet 355:1575-1581 Fuhrman B, Oiknine J, Aviram M (1994) Iron induces lipid peroxidation in cultured... | |
| |
Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. 
